The Contraceptive Devices Market is predicted to reach US$ by 2030 from US$ 12.9 billion in 2021, and to grow at a CAGR of 7.0% between the forecast period 2022 to 2030.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
By Product Type (Female and Male Contraceptive Devices), by Technology (Hormonal and Barrier Contraceptive), by Distribution Channel (Hospital pharmacies, Retail Pharmacies, Online Pharmacies, and Public Channel & NGOs)
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Pfizer, Inc., Merck & Co Inc, AbbVie, Inc., Teva Pharmaceutical Industries Limited, Ansell Ltd, Bayer AG,The Cooper Companies Inc., Veru Inc., Mayer Laboratories Inc., Church & Dwight Co Inc. among others
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Contraceptive Devices - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Contraceptive Devices - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Contraceptive Devices - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Contraceptive Devices - ANALYSIS & FORECAST, BY REGION
North America Contraceptive Devices
1. North America Contraceptive Devices , by Country
1. US
2. Canada
1. North America Contraceptive Devices , by Product
2. North America Contraceptive Devices , by Type
3. North America Contraceptive Devices , by Gender
4. North America Contraceptive Devices , by Sales Channel
3. Europe Contraceptive Devices
1. Europe Contraceptive Devices , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Contraceptive Devices , by Product
3. Europe Contraceptive Devices , by Type
4. Europe Contraceptive Devices , by Gender
5. Europe Contraceptive Devices , by Sales Channel
4. Asia Pacific Contraceptive Devices
1. Asia Pacific Contraceptive Devices , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Contraceptive Devices , by product
3. Asia Pacific Contraceptive Devices , by Type
4. Asia Pacific Contraceptive Devices , by Gender
5. Asia Pacific Contraceptive Devices , by Sales Channel
5. Rest of the World Contraceptive Devices
1. Rest of the World Contraceptive Devices , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Contraceptive Devices , by Product
3. Rest of the World Contraceptive Devices , by Type
4. Rest of the World Contraceptive Devices , by Gender
5. Rest of the World Contraceptive Devices , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 40